Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Ir O P Catalyst. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111848322B details a novel chiral phosphoric acid catalyzed resolution for axially chiral oxindole-substituted styrenes, offering high enantioselectivity and mild conditions for pharmaceutical intermediate manufacturing.
Novel chiral phosphoric acid catalyzed synthesis of N-N axis pyrroles. High yield, mild conditions, suitable for pharmaceutical intermediate manufacturing.
Patent CN107698590B details a novel asymmetric [3+2] cyclization for chiral carbocyclic purine nucleosides, offering high yields and enantioselectivity for reliable pharmaceutical intermediate supply.
Patent CN111777637B discloses a novel oxindole-derived phosphine catalyst enabling mild asymmetric cyclizations with excellent yields and supply chain stability.
Patent CN111848322B details a novel chiral phosphoric acid catalyzed resolution for axially chiral oxindole-substituted styrenes, offering high enantioselectivity and mild conditions for pharmaceutical intermediate manufacturing.
Patent CN111848322B details a novel chiral phosphoric acid resolution method for axially chiral oxindole-substituted styrenes, offering high enantioselectivity and mild conditions for pharmaceutical manufacturing.
Patent CN113980044B reveals a novel Ir-O-P catalyzed diboration method. This breakthrough enables cost-effective, scalable production of high-purity organoboron intermediates for drug discovery.
Discover novel axial chiral oxindole-derived styrene phosphine catalysts from patent CN111777637B. Enables asymmetric cyclization with mild conditions and scalable synthesis for fine chemical manufacturing.
Patent CN105056991B reveals spirocyclic phosphazene catalysts enabling high ee asymmetric synthesis. Offers cost reduction and scalable supply for pharma intermediates.
Patent CN114524701B reveals a novel organocatalytic route for N-N axis chiral pyrroles with high cytotoxicity, offering cost-effective API intermediate manufacturing solutions.
Patent CN114524701B reveals a novel chiral phosphoric acid catalyzed route for N-N axis chiral pyrroles with high enantioselectivity and cytotoxic activity.
Patent CN111848322B details a novel chiral phosphoric acid catalyzed resolution for axially chiral oxindole styrenes, offering high enantioselectivity and mild conditions for scalable pharmaceutical intermediate production.
Novel oxindole-derived styrene phosphine catalysts enabling high-yield asymmetric cyclizations with mild conditions for fine chemical manufacturing.
Novel axial chiral phosphine catalyst synthesis via chiral phosphoric acid. High ee, mild conditions. Ideal for asymmetric hydrosilylation and coupling. Reliable supplier for pharma intermediates.
Patent CN101143862B details novel chiral ionic thiourea catalysts offering high enantioselectivity and recyclability for pharmaceutical intermediate manufacturing.
Novel biaryl-based ligand enables high-yield palladium-catalyzed asymmetric allylic substitution with exceptional enantioselectivity and simplified synthesis.
Patent CN111777637B details novel indole-derived styrene phosphine catalysts enabling high-yield asymmetric cyclizations with mild conditions.
Novel organocatalytic method for high-purity axial chiral indole-naphthalenes. Efficient scale-up and cost-effective production for asymmetric catalysis applications.
Novel chiral phosphoric acid catalyzed resolution method for high-purity axially chiral oxindole-substituted styrenes, offering scalable synthesis for pharmaceutical intermediates.
Patent CN100389877C details a novel PEG-supported ruthenium catalyst enabling ambient pressure asymmetric hydrogenation, offering significant cost reduction and supply chain reliability for API manufacturing.